1-6 of 6
Eunice Y. Lau
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 5958: Exploring AKR1C3 as a therapeutic target to overcome erlotinib resistance in lung adenocarcinoma

Free
William C. Cho, Kwan P. Li, Chi F. Wong, King Y. Fung, James C. Chow, Ka M. Cheung, Jeffrey C. Chan, Eunice Y. Lau
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 5958.
https://doi.org/10.1158/1538-7445.AM2024-5958
Published: 22 March 2024
View articletitled, Abstract 5958: Exploring AKR1C3 as a therapeutic target to overcome erlotinib resistance in lung adenocarcinoma
Journal Articles

Abstract 5155: Noninvasive detection of HER2 amplification in breast cancer with plasma DNA digital PCR

Free
William C. Cho, Eunice Y. Lau, Jeffrey C. Chan, Anna Y. Tai, Alex K. Leung, Anthony K. Leung, Michelle O. Szeto, Elizabeth Y. Chuk, Tony Y. Yuen, Molly W. Fung, Roger K. Ngan
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 5155.
https://doi.org/10.1158/1538-7445.AM2022-5155
Published: 15 June 2022
View articletitled, Abstract 5155: Noninvasive detection of HER2 amplification in breast cancer with plasma DNA digital PCR
Journal Articles

EPHB2 Activates β-Catenin to Enhance Cancer Stem Cell Properties and Drive Sorafenib Resistance in Hepatocellular Carcinoma

Available to Purchase
Hoi Wing Leung, Carmen Oi Ning Leung, Eunice Y. Lau, Katherine Po Sin Chung, Etienne H. Mok, Martina Mang Leng Lei, Rainbow Wing Hei Leung, Man Tong, Vincent W. Keng, Cong Ma, Qian Zhao, Irene Oi Lin Ng, Stephanie Ma, Terence K. Lee
Journal: Cancer Research
Cancer Res (2021) 81 (12): 3229–3240.
https://doi.org/10.1158/0008-5472.CAN-21-0184
Published: 15 June 2021
View articletitled, EPHB2 Activates β-Catenin to Enhance Cancer Stem Cell Properties and Drive Sorafenib Resistance in Hepatocellular Carcinoma
Open the PDF for EPHB2 Activates β-Catenin to Enhance Cancer Stem Cell Properties and Drive Sorafenib Resistance in Hepatocellular Carcinoma in another window
Includes: Supplementary data
Journal Articles

Abstract 3578: Comprehensive pharmacogenomic analysis establishes lncRNAs as protein-coding independent biomarker of drug response in human cancers

Free
Aritro Nath, Eunice Y. Lau, Adam M. Lee, Paul Geeleher, William C. Cho, R. Stephanie Huang
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 3578.
https://doi.org/10.1158/1538-7445.AM2019-3578
Published: 01 July 2019
View articletitled, Abstract 3578: Comprehensive pharmacogenomic analysis establishes lncRNAs as protein-coding independent biomarker of drug response in human cancers
Journal Articles

IRAK1 Augments Cancer Stemness and Drug Resistance via the AP-1/AKR1B10 Signaling Cascade in Hepatocellular Carcinoma

Free
Bowie Y. Cheng, Eunice Y. Lau, Hoi-Wing Leung, Carmen Oi-Ning Leung, Nicole P. Ho, Shilpa Gurung, Lily K. Cheng, Chi Ho Lin, Regina Cheuk-Lam Lo, Stephanie Ma, Irene Oi-Lin Ng, Terence K. Lee
Journal: Cancer Research
Cancer Res (2018) 78 (9): 2332–2342.
https://doi.org/10.1158/0008-5472.CAN-17-2445
Published: 30 April 2018
View articletitled, IRAK1 Augments Cancer Stemness and Drug Resistance via the AP-1/AKR1B10 Signaling Cascade in Hepatocellular Carcinoma
Open the PDF for IRAK1 Augments Cancer Stemness and Drug Resistance via the AP-1/AKR1B10 Signaling Cascade in Hepatocellular Carcinoma in another window
Includes: Supplementary data
Journal Articles

Abstract 2895: Octamer-4/microRNA-1246 signaling axis drives Wnt/β-catenin activation in liver cancer stem cells

Free
Stella Chai, Kai-Yu Ng, Man Tong, Eunice Y. Lau, Terence K. Lee, Kwok Wah Chan, Yun Fei Yuan, Tan To Cheung, Siu Tim Cheung, Xiao Qi Wang, Nathalie Wong, Chung Mau Lo, Kwan Man, Xin Yuan Guan, Stephanie K. Ma
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 2895.
https://doi.org/10.1158/1538-7445.AM2017-2895
Published: 01 July 2017
View articletitled, Abstract 2895: Octamer-4/microRNA-1246 signaling axis drives Wnt/β-catenin activation in liver cancer stem cells